GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT3) » Definitions » PB Ratio

Sartorius AG (XTER:SRT3) PB Ratio : 5.63 (As of Dec. 02, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-02), Sartorius AG's share price is €217.80. Sartorius AG's Book Value per Share for the quarter that ended in Sep. 2024 was €38.66. Hence, Sartorius AG's PB Ratio of today is 5.63.

Good Sign:

Sartorius AG stock PB Ratio (=4.51) is close to 10-year low of 4.13

The historical rank and industry rank for Sartorius AG's PB Ratio or its related term are showing as below:

XTER:SRT3' s PB Ratio Range Over the Past 10 Years
Min: 4.13   Med: 10.34   Max: 43.63
Current: 4.51

During the past 13 years, Sartorius AG's highest PB Ratio was 43.63. The lowest was 4.13. And the median was 10.34.

XTER:SRT3's PB Ratio is ranked worse than
75.45% of 786 companies
in the Medical Devices & Instruments industry
Industry Median: 2.31 vs XTER:SRT3: 4.51

During the past 12 months, Sartorius AG's average Book Value Per Share Growth Rate was 27.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 26.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 25.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 19.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Sartorius AG was 34.90% per year. The lowest was -1.60% per year. And the median was 15.60% per year.

Back to Basics: PB Ratio


Sartorius AG PB Ratio Historical Data

The historical data trend for Sartorius AG's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG PB Ratio Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.10 22.79 32.31 12.70 11.03

Sartorius AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.65 11.03 9.53 5.59 6.52

Competitive Comparison of Sartorius AG's PB Ratio

For the Medical Instruments & Supplies subindustry, Sartorius AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's PB Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius AG's PB Ratio falls into.



Sartorius AG PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Sartorius AG's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=217.80/38.655
=5.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Sartorius AG  (XTER:SRT3) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Sartorius AG PB Ratio Related Terms

Thank you for viewing the detailed overview of Sartorius AG's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Executives
Dr. Lothar Ewald Kappich Supervisory Board
Dr. Joachim Kreuzburg Board of Directors

Sartorius AG Headlines

No Headlines